Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Cyndrx, LLC

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Cyndrx, LLC

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Cyndrx, LLC. It includes 1 original PMA approval. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jun 5, 2026 to Jun 5, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code MGB appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P230038, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 205 Powell Pl., Suite 124, Brentwood, TN, 37027. Recorded on P230038, decision dated Jun 5, 2026.

Changes described in PMA records

P230038: AbsorbaSeal 5.6.7F Vascular Closure Device

FDA’s recorded scope: the AbsorbaSeal 5.6.7F Vascular Closure Device. This device is indicated for use in percutaneous closure of femoral arterial access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures utilizing 5, 6, or 7F procedural sheaths.

Jun 5, 2026

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Cyndrx, LLCPMA approvalJun 5, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.